Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1984 Mar;199(3):276–280. doi: 10.1097/00000658-198403000-00005

Plasma cholecystokinin response to oral fat in patients with Billroth I and Billroth II gastrectomy.

W P Hopman, J B Jansen, C B Lamers
PMCID: PMC1353392  PMID: 6703789

Abstract

The present study was undertaken to determine whether bypassing the duodenum in patients with Billroth II gastrectomy affects plasma cholecystokinin (CCK) release in response to ingestion of fat. Plasma CCK concentrations were measured by radioimmunoassay using two antibodies; antibody 1703 binds to all carboxyl-terminal CCK-peptides containing at least 14 amino acid residues, while antibody T204 is specific for the sulphated tyrosine region of CCK. There were no significant differences among fasting plasma CCK concentrations in seven patients with Billroth II gastrectomy (1.3 +/- 0.4 fmol/ml, antibody 1703; 2.6 +/- 0.4 fmol/ml, antibody T204), six patients with Billroth I gastrectomy (0.6 +/- 0.3 fmol/ml, antibody 1703; 2.9 +/- 0.5 fmol/ml, antibody T204), and nine normal subjects (0.7 +/- 0.1 fmol/ml, antibody 1703; 1.9 +/- 0.3 fmol/ml, antibody T204). Ingestion of 250 ml 20% Intralipid induced similar increases in plasma CCK in patients with Billroth II gastrectomy (11.2 +/- 2.0 fmol/ml, antibody 1703; 10.1 +/- 2.4 fmol/ml, antibody T204) as in patients with Billroth I gastrectomy (11.8 +/- 2.0 fmol/ml, antibody 1703; 8.4 +/- 1.1 fmol/ml, antibody T204). However, the increments in plasma CCK in patients with gastrectomy (11.5 +/- 1.4 fmol/ml, antibody 1703; 9.3 +/- 1.4 fmol/ml, antibody T204) were significantly (p less than 0.01) greater than those in normal subjects (4.7 +/- 0.8 fmol/ml, antibody 1703; 4.1 +/- 0.7 fmol/ml). Similarly, the integrated plasma CCK secretion in patients with Billroth II gastrectomy (510 +/- 58 fmol/ml X 120 min, antibody 1703; 458 +/- 69 fmol/ml X 120 min, antibody T204) and in patients with Billroth I gastrectomy (457 +/- 143 fmol/ml X 120 min, antibody 1703; 365 +/- 61 fmol/ml X 120 min, antibody T204) were significantly (p less than 0.05) greater than in normal subjects (230 +/- 49 fmol/ml X 120 min, antibody 1703; 162 +/- 24 fmol/ml X 120 min, antibody T204). It is concluded that the plasma CCK response to oral fat is significantly greater in patients with partial gastrectomy than in normal subjects, and that patients with Billroth I and Billroth II gastrectomy have similar increases in plasma CCK after ingestion of fat.

Full text

PDF
276

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bryant M. G., Bloom S. R. Distribution of the gut hormones in the primate intestinal tract. Gut. 1979 Aug;20(8):653–659. doi: 10.1136/gut.20.8.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Calam J., Ellis A., Dockray G. J. Identification and measurement of molecular variants of cholecystokinin in duodenal mucosa and plasma. Diminished concentrations in patients with celiac disease. J Clin Invest. 1982 Jan;69(1):218–225. doi: 10.1172/JCI110433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fletcher D. M., Clark C. G. Gall-stones and gastric surgery. A review. Br J Surg. 1968 Dec;55(12):895–899. doi: 10.1002/bjs.1800551205. [DOI] [PubMed] [Google Scholar]
  4. GRIFFITHS J. M., HOLMES G. CHOLECYSTITIS FOLLOWING GASTRIC SURGERY. Lancet. 1964 Oct 10;2(7363):780–782. doi: 10.1016/s0140-6736(64)90560-4. [DOI] [PubMed] [Google Scholar]
  5. Go V. L., Hofmann A. F., Summerskill W. H. Pancreozymin bioassay in man based on pancreatic enzyme secretion: potency of specific amino acids and other digestive products. J Clin Invest. 1970 Aug;49(8):1558–1564. doi: 10.1172/JCI106373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Go V. L., Ryan R. J., Summerskill W. H. Radioimmunoassay of porcine cholecystokinin-pancreozymin. J Lab Clin Med. 1971 Apr;77(4):684–689. [PubMed] [Google Scholar]
  7. HORWITZ A., KIRSON S. M. CHOLECYSTITIS AND CHOLELITHIASIS AS A SEQUEL TO GASTRIC SURGERY: A CLINICAL IMPRESSION. Am J Surg. 1965 Jun;109:760–762. doi: 10.1016/s0002-9610(65)80048-4. [DOI] [PubMed] [Google Scholar]
  8. Jansen J. B., Lamers C. B. Molecular forms of cholecystokinin in human plasma during infusion of bombesin. Life Sci. 1983 Nov 28;33(22):2197–2205. doi: 10.1016/0024-3205(83)90291-6. [DOI] [PubMed] [Google Scholar]
  9. Jansen J. B., Lamers C. B. Radioimmunoassay of cholecystokinin in human tissue and plasma. Clin Chim Acta. 1983 Jul 15;131(3):305–316. doi: 10.1016/0009-8981(83)90100-6. [DOI] [PubMed] [Google Scholar]
  10. Johnson A. G., McDermott S. J. Sensitive bioassay of cholecystokinin in human serum. Lancet. 1973 Sep 15;2(7829):589–591. doi: 10.1016/s0140-6736(73)92416-1. [DOI] [PubMed] [Google Scholar]
  11. MAJOOR C. L. H., SUREN T. J. J. Gall-bladder complications following resection of the stomach for peptic ulcer. Br Med J. 1947 Jul 5;2(4513):8–11. doi: 10.1136/bmj.2.4513.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MacGregor I., Parent J., Meyer J. H. Gastric emptying of liquid meals and pancreatic and biliary secretion after subtotal gastrectomy or truncal vagotomy and pyloroplasty in man. Gastroenterology. 1977 Feb;72(2):195–205. [PubMed] [Google Scholar]
  13. Maton P. N., Selden A. C., Chadwick V. S. Large and small forms of cholecystokinin in human plasma: measurement using high pressure liquid chromatography and radioimmunoassay. Regul Pept. 1982 Oct;4(5):251–260. doi: 10.1016/0167-0115(82)90118-5. [DOI] [PubMed] [Google Scholar]
  14. Mutt V., Jorpes J. E. Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin. Eur J Biochem. 1968 Oct 17;6(1):156–162. doi: 10.1111/j.1432-1033.1968.tb00433.x. [DOI] [PubMed] [Google Scholar]
  15. Rehfeld J. F. Immunochemical studies on cholecystokinin. I. Development of sequence-specific radioimmunoassays for porcine triacontatriapeptide cholecystokinin. J Biol Chem. 1978 Jun 10;253(11):4016–4021. [PubMed] [Google Scholar]
  16. Solomon T. E., Grossman M. I. Effect of atropine and vagotomy on response of transplanted pancreas. Am J Physiol. 1979 Feb;236(2):E186–E190. doi: 10.1152/ajpendo.1979.236.2.E186. [DOI] [PubMed] [Google Scholar]
  17. Straus E. Radioimmunoassay of gastrointestinal hormones. Gastroenterology. 1978 Jan;74(1):141–152. [PubMed] [Google Scholar]
  18. Straus E., Yalow R. S. Species specificity of cholecystokinin in gut and brain of several mammalian species. Proc Natl Acad Sci U S A. 1978 Jan;75(1):486–489. doi: 10.1073/pnas.75.1.486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Walsh J. H., Lamers C. B., Valenzuela J. E. Cholecystokinin-octapeptidelike immunoreactivity in human plasma. Gastroenterology. 1982 Mar;82(3):438–444. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES